Gefitinib Research and Insights
Gefitinib Research and Insights
Public Group
Active 10 months, 2 weeks ago
Join the “Gefitinib Research and Insights” group to explore the role of gefitinib in cancer therapy. As an EGFR inhibitor similar to erlotinib, gefitinib effectively disrupts signaling in cancers with mutated and overactive EGFR. However, challenges such as resistance due to additional mutations are critical topics for discussion. Engage with experts, share research findings, and discuss strategies to overcome these resistances for more effective treatments.
